Efficacy of a probiotic supplement in patients with atopic dermatitis: a randomized, double-blind, placebo-controlled clinical trial
Volume 31, numéro 2, March-April 2021
[1]Chamlin S.L., Chren M.-M. Quality-of-life outcomes and measurement in childhood atopic dermatitis. Immunol Allergy Clin. 2010;30:281-288.
[2]Huang R., Ning H., Shen M., Li J., Zhang J., Chen X. Probiotics for the treatment of atopic dermatitis in children: a systematic review and meta-analysis of randomized controlled trials. Front Cell Infect Microbiol. 2017;7:392.
[3]Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66:8-16.
[4]Sevelsted A., Stokholm J., Bønnelykke K., Bisgaard H. Cesarean section and chronic immune disorders. Pediatrics. 2015;135:e92-e98.
[5]Flohr C., Pascoe D., Williams H.C. Atopic dermatitis and the ‘hygiene hypothesis’: too clean to be true? Br J Dermatol. 2005;152:202-216.
[6]Belkaid Y., Segre J.A. Dialogue between skin microbiota and immunity. Science. 2014;346:954-959.
[7]Mansouri Y., Guttman-Yassky E. Immune pathways in atopic dermatitis, and definition of biomarkers through broad and targeted therapeutics. J Clin Med. 2015;4:858-873.
[8]Leung D.Y., Guttman-Yassky E. Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches. J Allergy Clin Immunol. 2014;134:769-779.
[9]Kosiewicz M.M., Zirnheld A.L., Alard P. Gut microbiota, immunity, and disease: a complex relationship. Front Microbiol. 2011;2:180.
[10]Arck P., Handjiski B., Hagen E. Is there a ‘gut–brain–skin axis’? Exp Dermatol. 2010;19:401-405.
[11]Kosiewicz M.M., Dryden G.W., Chhabra A., Alard P. Relationship between gut microbiota and development of T cell associated disease. FEBS Lett. 2014;588:4195-4206.
[12]Gittler J.K., Shemer A., Suárez-Fariñas M. Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J Allergy Clin Immunol. 2012;130:1344-1354.
[13]Soumelis V., Reche P.A., Kanzler H. Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP. Nat Immunol. 2002;3:673.
[14]Paul W.E., Zhu J. How are T H 2-type immune responses initiated and amplified? Nat Rev Immunol. 2010;10:225.
[15]Sano Y., Masuda K., Tamagawa-Mineoka R. Thymic stromal lymphopoietin expression is increased in the horny layer of patients with atopic dermatitis. Clin Exp Immunol. 2013;171:330-337.
[16]Morita E., Takahashi H., Niihara H. Stratum corneum TARC level is a new indicator of lesional skin inflammation in atopic dermatitis. Allergy. 2010;65:1166-1172.
[17]Ng J.P.X., Liew H.M., Ang S.B. Use of emollients in atopic dermatitis. J Eur Acad Dermatol Venereol. 2015;29:854-857.
[18]Del Rosso J.Q. Monoclonal antibody therapies for atopic dermatitis: where are we now in the spectrum of disease management? J Clin Aesth Dermatol. 2019;12:39.
[19]Retzler J., Smith A., Reaney M., Rout R., Hudson R. Process utilities for topical treatment in atopic dermatitis. Qual Life Res. 20191-9.
[20]Jeziorkowska R., Sysa-Jędrzejowska A., Samochocki Z. Topical steroid therapy in atopic dermatitis in theory and practice. Adv Dermatol Allerg. 2015;32:162.
[21]Panduru M., Panduru N.M., Sălăvăstru C.M., Tiplica G.S. Probiotics and primary prevention of atopic dermatitis: a meta-analysis of randomized controlled studies. J Eur Acad Dermatol Venereol. 2015;29:232-242.
[22]Niers L., Martín R., Rijkers G. The effects of selected probiotic strains on the development of eczema (the PandA study). Allergy. 2009;64:1349-1358.
[23]Wickens K., Black P.N., Stanley T.V. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2008;122:788-794.
[24]Rosenfeldt V., Benfeldt E., Nielsen S.D. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol. 2003;111:389-395.
[25]Niccoli A.A., Artesi A.L., Candio F. Preliminary results on clinical effects of probiotic Lactobacillus salivarius LS01 in children affected by atopic dermatitis. J Clin Gastroenterol. 2014;48:S34-S36.
[26]Gueniche A., Philippe D., Bastien P. Randomised double-blind placebo-controlled study of the effect of Lactobacillus paracasei NCC 2461 on skin reactivity. Benef Microbes. 2013;5:137-145.
[27]Carding S., Verbeke K., Vipond D.T., Corfe B.M., Owen L.J. Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis. 2015;26:26191.
[28]Pessi T., Sütas Y., Hurme M., Isolauri E. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy. 2000;30:1804-1808.
[29]Kalliomäki M., Salminen S., Arvilommi H., Kero P., Koskinen P., Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 2001;357:1076-1079.
[30]Ouwehand AC, Salminen S, Isolauri E. Probiotics: an overview of beneficial effects. In: Lactic Acid Bacteria: Genetics, Metabolism and Applications. Springer, Dordrecht, 2002: 279-89.
[31]Hattori K., Yamamoto A., Sasai M. Effects of administration of bifidobacteria on fecal microflora and clinical symptoms in infants with atopic dermatitis. Arerugi. 2003;52:20-30.
[32]Matsumoto M., Kakizoe K., Benno Y. Comparison of fecal microbiota and polyamine concentration in adult patients with intractable atopic dermatitis and healthy adults. Microbiol Immunol. 2007;51:37-46.
[33]Park C.W., Youn M., Jung Y.M. New functional probiotic Lactobacillus sakei probio 65 alleviates atopic symptoms in the mouse. J Med Food. 2008;11:405-412.
[34]Savilahti E., Kuitunen M., Vaarala O. Pre and probiotics in the prevention and treatment of food allergy. Curr Opin Allergy Clin Immunol. 2008;8:243-248.
[35]Adams C.A. The probiotic paradox: live and dead cells are biological response modifiers. Nutr Res Rev. 2010;23:37-46.
[36]Chapman C.M.C., Gibson G.R., Rowland I. Health benefits of probiotics: are mixtures more effective than single strains? Eur J Nutr. 2011;50:1-17.
[37]Wickens K., Black P., Stanley T.V. A protective effect of Lactobacillus rhamnosus HN 001 against eczema in the first 2 years of life persists to age 4 years. Clin Exp Allergy. 2012;42:1071-1079.
[38]Morgan A.R., Han D.Y., Wickens K. Differential modification of genetic susceptibility to childhood eczema by two probiotics. Clin Exp Allergy. 2014;44:1255-1265.
[39]Meneghin F., Fabiano V., Mameli C., Zuccotti G.V. Probiotics and atopic dermatitis in children. Pharmaceuticals. 2012;5:727-744.
[40]Foolad N., Armstrong A.W. Prebiotics and probiotics: the prevention and reduction in severity of atopic dermatitis in children. Benef Microbes. 2014;5:151-160.
[41]Han Y., Kim B., Ban J. A randomized trial of Lactobacillus plantarum CJLP 133 for the treatment of atopic dermatitis. Ped Allergy Immunol. 2012;23:667-673.
[42]Tetens I. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of a health claim related to Rhodiola rosea L. extract and reduction of mental fatigue pursuant to Article 13 (5) of Regulation (EC) No 1924/2006. 2012.
[43]O’Neill C.A., Monteleone G., McLaughlin J.T., Paus R. The gut-skin axis in health and disease: A paradigm with therapeutic implications. BioEssays. 2016;38:1167-1176.
[45]Majamaa H., Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol. 1997;99:179-185.
[46]Weston S., Halbert A., Richmond P., Prescott S.L. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Childhood. 2005;90:892-897.
[47]Yeşilova Y., Çalka Ö., Akdeniz N., Berktaş M. Effect of probiotics on the treatment of children with atopic dermatitis. Annal Dermatol. 2012;24:189-193.
[48]Roudsari M.R., Karimi R., Sohrabvandi S., Mortazavian A.M. Health effects of probiotics on the skin. Crit Rev Food Sci Nutr. 2015;55:1219-1240.
[49]Mezzasalma V., Manfrini E., Ferri E. A randomized, double-blind, placebo-controlled trial: the efficacy of multispecies probiotic supplementation in alleviating symptoms of irritable bowel syndrome associated with constipation. Biomed Res Int. 2016;2016:4740907.
[50]Salem I., Ramser A., Isham N., Ghannoum M.A. The gut microbiome as a major regulator of the gut-skin axis. Front Microbiol. 2018;9:1459.